France Myocardial Infarction Market to Reach $388.3 Million by 2035

France myocardial infarction market was valued at $242.3 million in 2025 and is projected to reach $388.3 million by 2035, growing at a CAGR of 4.9% during the forecast period (2026–2035). Market growth is primarily driven by the increasing prevalence of cardiovascular diseases and the rising demand for advanced interventional and monitoring devices. According to the World Health Organization (WHO), cardiovascular diseases account for nearly 32% of total global casualties, with ischemic heart diseases being the leading cause. This growing disease burden is significantly increasing hospital admissions and procedural volumes in France, thereby driving demand for medical devices such as pacemakers, catheters, and implantable cardioverter defibrillators across hospitals and speciality centres.

Browse the full report description of “France Myocardial Infarction Market Size, Share & Trends Analysis Report by Treatment Type (Pharmacological Treatment, Interventional Procedures, Adjunct & Supportive Care), by Medical Device Type (Left Ventricular Assist Device, Pacemaker, Catheters, Implantable Cardioverter Defibrillator, Others), by End-Use Industry (Hospitals, Specialty Centres, ASCs), and Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/france-myocardial-infarction-market

Rising Interventional Procedures Enhancing Cardiac Care Outcomes

The key players in the France myocardial infarction market include top companies such as Johnson & Johnson, Abbott, Medtronic, Siemens Healthineers, and GE HealthCare, among others. The market is witnessing strong adoption of minimally invasive interventional procedures and advanced cardiac monitoring solutions. Increasing investments in healthcare infrastructure and growing awareness regarding early diagnosis are further supporting market expansion across hospitals and speciality centres in France.

• In March 2026, Medtronic plc announced results from its ALERT trial showing that AI-enabled clinician alerts significantly improved the evaluation and treatment of heart valve disease. The study demonstrated a 40% increase in valve interventions and faster specialist referrals through automated electronic health record notifications. This advancement highlights the growing role of AI in cardiovascular care, thereby indirectly supporting improved clinical pathways for myocardial infarction management.

• In August 2025, Abbott announced that its Navitor TAVI system received CE Mark approval in Europe for an expanded indication to treat patients with severe aortic stenosis across all surgical risk categories. The minimally invasive device, supported by data from the VANTAGE trial presented at the European Society of Cardiology Congress 2025, significantly broadens access to transcatheter valve interventions. This development highlights advancements in cardiovascular interventional technologies, indirectly contributing to improvements in cardiac care infrastructure for myocardial infarction management in France.

• In October 2025, Terumo Corporation announced FDA clearance for its OPUSWAVE dual sensor imaging system, combining IVUS and OFDI technologies to enhance coronary artery disease assessment. The system enables comprehensive visualization during percutaneous coronary intervention (PCI), improving procedural efficiency and clinical decision-making in cardiac care. This advancement supports the growing adoption of image-guided interventions, strengthening treatment capabilities in the France myocardial infarction market.

Market Coverage

• The market number available for – 2025–2035
• Base year- 2025
• Forecast period- 2026–2035
• Segment Covered-
• By Treatment Type
• By Medical Device Type
• By End-User
• Competitive Landscape: Johnson & Johnson, Abbott, Medtronic, Siemens Healthineers, and GE HealthCare, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

France Myocardial Infarction Market Report Segment

By Treatment Type

• Pharmacological Treatment
• Interventional Procedures
• Adjunct & Supportive Care

By Device Type

• Left Ventricular Assist Device
• Pacemaker
• Catheters
• Implantable Cardioverter Defibrillator
• Others

By End-User

• Hospitals
• Specialty Centres
• ASCs

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/france-myocardial-infarction-market